Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice

BACKGROUND: The advent of oral disease-modifying therapies fundamentally changed the treatment of multiple sclerosis. Nevertheless, impressions of their relative efficacy and tolerability are primarily founded on expert opinion. OBJECTIVE: The purpose of this study was to determine whether oral dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Longbrake, Erin E, Cross, Anne H, Salter, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340186/
https://www.ncbi.nlm.nih.gov/pubmed/28280599
http://dx.doi.org/10.1177/2055217316677868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340186/
https://www.ncbi.nlm.nih.gov/pubmed/28280599
http://dx.doi.org/10.1177/2055217316677868

Ejemplares similares